Combination of effective parts for curing chronic hepatitis, preparation and usage
A technology of effective parts and compositions, applied in the field of effective part compositions for the treatment of chronic hepatitis and its preparation and application
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2006-02-01
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
Technical field:
[0001] The invention belongs to the field of traditional Chinese medicine development, and relates to a composition of effective parts for treating chronic hepatitis and its preparation and application, in particular to total glycosides of Bupleurum glycosides, total flavonoids of Scutellaria baicalensis and The active part composition composed of total glycyrrhizin and its preparation and its application in the preparation of drugs with the functions of anti-hepatitis virus, liver protection and enzyme reduction, and immune function regulation. Background technique:
[0002] Chronic hepatitis refers to liver inflammation, abnormal histological and biochemical signs that persist for more than 6 months, and the condition does not improve significantly, or there are active inflammatory changes in the liver. It is not a single disease, but includes chronic liver diseases caused by various etiologies. Chronic hepatitis can be caused by viruses, drugs, alcohol a...
Examples
Embodiment 1
[0031] Take a certain proportion of the effective fractions composed of total glucosides of Bupleurum glycosides, total flavonoids of Scutellaria baicalensis and total glycosides of glycyrrhizin, dry, pulverize, pass through an 80 mesh sieve, mix them with microcrystalline cellulose through an 80 mesh sieve, and make granules with 95% ethanol , air-dried, sieved with 20 meshes, filled with capsules, polished and packaged.
[0032] Prescription Composition (1000 Capsules) Bupleuradin 30g
[0033] Total Flavonoids of Scutellaria baicalensis 70g
[0034] Glycyrrhizin 50g
[0035] Microcrystalline Cellulose 75g
[0036] Its technological process sees accompanying drawing 1 of specification sheet.
Embodiment 2
[0038] Take a certain proportion of the active fraction group composed of total glucosides of Bupleurum, baicalin and glycyrrhizin, dry, pulverize, pass through an 80 mesh sieve, and mix evenly with microcrystalline cellulose and sodium carboxymethyl starch through an 80 mesh sieve, and mix with 5 Granules made of %PVP, air-dried, granulated with a 20-mesh sieve, added with magnesium stearate, and compressed into tablets.
[0039] Prescription composition: (1000 tablets) Bupleurum glycosides 10g
[0040] Baicalin 30g
[0041] Glycyrrhizin 4g
[0042] Sodium carboxymethyl starch 5g
[0043] Microcrystalline Cellulose 73g
[0045] Its technological process is shown in accompanying drawing 2 of specification sheet.
[0046] The following pharmacological experiment results illustrate its drug effect: